Fifteen PNNL scientists are part of a team that has identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
PNNL will lead two new projects to advance resilient distribution systems and partner on three additional demonstrations aimed at validating new approaches and technologies to make the aging grid more resilient and secure.
PNNL scientists are part of a nationwide effort to learn more about the role of proteins in cancer biology and to use that information to benefit cancer patients.
PNNL scientists have gotten one of the most in-depth looks ever at the developing lung, characterizing hundreds of lipids and thousands of proteins from samples as small as just 4,000 cells.